Showing results (41-50 of 82) with videos related to
Sort By:
Pageof 9
Medicine|November 25, 2020
Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomy: A bimodal distributionAndrew K Y Fung, Nicole M Y Cheng, Charing C N Chong, et al.World Journal of Surgery|November 6, 2022
The Impact of Involved Resection Margin on Recurrence and Survival After Pancreaticoduodenectomy for Periampullary Carcinoma, with Emphasis on Pancreatic Head CarcinomaKit-Fai Lee, Hon-Ting Lok, Andrew K Y Fung, et al.Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|March 29, 2019
Enhanced recovery after surgery for liver resectionC C N Chong, W Y Chung, Y S Cheung, et al.Cancer|June 23, 2017
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinomaStephen L Chan, Winnie Yeo, Frankie Mo, et al.Langenbeck'S Archives of Surgery|March 14, 2023
Minimally invasive versus open liver resection for hepatocellular carcinoma: a propensity score matching analysis of 224 patientsKam Cheung Wong, Kit Fai Lee, Eugene Y J Lo, et al.Journal of Gastroenterology and Hepatology|June 4, 2016
Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinomaAnthony W H Chan, Charing C N Chong, Frankie K F Mo, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 9, 2016
Systematic evaluation of circulating inflammatory markers for hepatocellular carcinomaStephen L Chan, Anthony W H Chan, Allen K C Chan, et al.Journal of Gastroenterology and Hepatology|March 19, 2016
Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinomaAnthony W H Chan, Charing C N Chong, Frankie K F Mo, et al.Alimentary Pharmacology & Therapeutics|April 15, 2011
Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinomaJ S-W Wong, G L-H Wong, K K-F Tsoi, et al.Journal of Cellular and Molecular Medicine|August 13, 2020
Genetic variation in ABCB5 associates with risk of hepatocellular carcinomaIdy C-Y Leung, Charing C-N Chong, Tan T Cheung, et al.Pageof 9